- Home
- PHVS vs SEM Comparison
PHVS vs SEM Comparison
Compare PHVS & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- SEM
- Stock Information
- Founded
- PHVS 2015
- SEM 1996
- Country
- PHVS Switzerland
- SEM United States
- Employees
- PHVS N/A
- SEM N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- SEM Hospital/Nursing Management
- Sector
- PHVS Health Care
- SEM Health Care
- Exchange
- PHVS Nasdaq
- SEM Nasdaq
- Market Cap
- PHVS 1.6B
- SEM 1.6B
- IPO Year
- PHVS 2021
- SEM 2009
- Fundamental
- Price
- PHVS $22.46
- SEM $13.39
- Analyst Decision
- PHVS Buy
- SEM Buy
- Analyst Count
- PHVS 6
- SEM 4
- Target Price
- PHVS $36.50
- SEM $16.33
- AVG Volume (30 Days)
- PHVS 217.3K
- SEM 1.2M
- Earning Date
- PHVS 11-12-2025
- SEM 10-30-2025
- Dividend Yield
- PHVS N/A
- SEM 1.86%
- EPS Growth
- PHVS N/A
- SEM N/A
- EPS
- PHVS N/A
- SEM 0.87
- Revenue
- PHVS N/A
- SEM $5,368,760,000.00
- Revenue This Year
- PHVS N/A
- SEM $4.99
- Revenue Next Year
- PHVS N/A
- SEM $5.07
- P/E Ratio
- PHVS N/A
- SEM $15.35
- Revenue Growth
- PHVS N/A
- SEM 45.29
- 52 Week Low
- PHVS $11.51
- SEM $11.65
- 52 Week High
- PHVS $26.33
- SEM $40.98
- Technical
- Relative Strength Index (RSI)
- PHVS 47.79
- SEM 45.39
- Support Level
- PHVS $21.99
- SEM $12.87
- Resistance Level
- PHVS $23.64
- SEM $14.59
- Average True Range (ATR)
- PHVS 1.28
- SEM 0.47
- MACD
- PHVS -0.01
- SEM -0.05
- Stochastic Oscillator
- PHVS 52.17
- SEM 28.61
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.